Incannex Healthcare Inc.

IXHL Healthcare Drug Manufacturers Specialty & Generic

Incannex Healthcare Inc.’s revenue for fiscal 2025 (year ended June 2025) was $86,000.00, up 616.7% from fiscal 2024. In the quarter to June 2026, revenue fell 92.3%, EPS grew 99.0% and free cash flow grew 327.7%, each against the same quarter a year earlier.

2.82 0.06 −2.08%
Market cap
$36.1M
P/E
0.0×
Fwd P/E
−2.4×
Dividend yield
—
F-score
3/9
Altman Z
−13.23
Beneish M
−5.82
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
48.81 41.56 48.27 47.51
Net Debt/EBITDA
13.17 18.69 9.98 10.89
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
0.29 (0.20) (0.40) (0.89)
Book value per Share
5.78 6.09 6.31 7.45
Free Cash Flow
3.38 (2.46) (4.63) (9.16)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Oct 2026